Other blood tests and tumor marker tests revealed no significant ... Only a few cases were detected through elevated serum tumor markers, such as AFP (45.05%), CEA (5.68%), and CA19-9 (29.21%). In ...

A woman was diagnosed with a brain tumor after she couldn’t read a single letter during her eye test. Gemma Hillier, 45, lost her dad, Rod, 73, in July 2018 after he was diagnosed with a ...

Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumor DNA can predict lung cancer outcome. Circulating tumor DNA (ctDNA ...

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) on December 5, 2024, Volume 16, Issue 22, titled "DNA-methylation age and ...

High levels of the cancer antigen 15-3 (CA 15-3) can indicate that breast cancer is present or has spread to other parts of the body. Among other things, the CA 15-3 blood test can reflect how ...

In the last few years, much attention has been paid to this novel tumor marker that can be determined in EDTA-plasma and in the feces. It has been used in diagnosis and surveillance of a variety ...

People with brain bleeds had nearly 7 times higher blood levels of a specific brain protein, called glial fibrillary acidic protein (GFAP), than those who had strokes caused by clots in a study ...

People who want to slow pace of aging are now signing up to find out their biological age Keeping up with the Kardashians has been quite a task, what with the first family of reality TV setting ...

Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumor DNA can predict lung cancer outcome in a Cancer Research UK-funded study.

President Donald Trump has vowed to be a peacemaker in his new term, but his aggressive early actions threaten to alienate US friends in a way that could hinder his ambitions, experts say.

We discuss the challenges such as immunosuppressive microenvironment, tumor heterogeneity, and physical barriers that limit CAR-T efficacy. Emerging strategies, such as logic-gated and dual-targeting ...